Novan Inc

pump-and-dump

With Stormy Paula at the helm, and pump &amp; dumpers on deck bailing, not exactly feeling good here about long term prospects of NOVN

$NOVN like a cheap whore this POS isn’t more than 5% pump and dump trash.

$NOVN should also note that fucking gummy bear ass bitch will pump and dump like $2 hooker.

$NOVN pump and dump trash once again 😂😂😂😂 down 20% in 30 mins 😂😂😂😂 fu*king trash

$NOVN well at least you know what to do with this pump and dump trash!

short

$NOVN notice how it touched 200MA and dropped, tells me fucking shorts are in on this. Bitches.

$NOVN  shorts, there’s no place for you, go away, paytience

price

but I’m trying to save you all headaches from this garbage Management that doesn’t care about stock price.

$NOVN crazy this price action on VRCA i dont understand this :D

⚠️ Warning: Please note that the price has risen more than 25% in only 2 days.

Why was there so much good news when the stock price was high and now there is no good news?

This is an indication that they wanted to deceive people when they bought at a high price in order to encourage people to buy at those high prices.

joke

Surprised no one’s told us this was trash today with a $.02 drop.

This is just a trash company that was pumped on hot air.

$NOVN 

What a joke of a company 
stock is even bigger joke.

but this is on you for investing in such a trash company.

$NOVN Am I the only brave soul who is buying at this ridiculous level?

scam

$NOVN Unless this garbage of manipulations is cleaned up, we brother will fight among ourselves in difference of opinions.

SELL ALL YOUR WORTHLESS SHARES AND BE DONE WITH THIS GARBAGE COMPANY. 😉

$QNGY 500% recovery won’t take long 

$TSLA complete garbage.

$NOVN every single day is fuckin&#39; red this stinky garbage

$NOVN Let’s look at this : NDA filed,
Creative factoring financing, marketing partnerships established,
Very promising product pipeline…
Personally, looks better than it had in a long time.

- Once the NDA for SB206 is submitted this week, price should have no problem breaking $2.25 resistence. .

NDA submission should give us a bump and keep us above as well.

$NOVN still on track to submit NDA by year end, which is great because the way this stock has sank it could have been bad if they delayed.

$NOVN today I will buy more it is a good chance for this price 
I believe will see it more than
$60 it is just one announcement in one minute just like this 😎

..better buckle up, might be the BEST investment youve ever made at these prices!

There are numerous catalysts this year which will continue to support and influence share price leading to the weeks prior to anticipated approval.

$NOVN 

Whatever conclusions you’d like to draw about the price movements today, we should celebrate the fundamental win.

$NOVN 

I have no problems getting off

My average price is $11

$NOVN 

More consolidation around this price level is only going to make things better I hope everyone realizes that.

Best share price impact would be any day next week in my opinion.

Looking forward to some awesome price action on these names again tomorrow!

$NOVN Profit taking overdone, perhaps we can start to rise again because we all know that future news is extremely positive for the company and stock price.

market

$NOVN extraordinarily bullish here after a successful at the market raise to get them through to approval

As the market for dermatological treatments continues to grow, Novan’s unique approach to addressing underlying causes of skin conditions could prove to be a game-changer.

$NOVN Holding up very well in this bloody market. 💪🏼

$NOVN 

All indications confirm that this company has a bright future and it owns a product that is not available in the market despite the great need for it.

Volatile market with many good daytrades

Bought more here with profits.

$NOVN Now they’re allowing the algos and buying programs to flip

They did good work 

Hats off to the market makers 

Any weak retail who sold will witness something that should help them the rest of their lives 

Now…let’s get it going…

application

This company has a significant chance of early FDA acceptance any day now.

Company structure is good, FDA claearance much closer compared to last years.

The NITRICIL platform technology offers a wide range of potential applications.

$NOVN I’m not over-stating or exaggerating for affect—-but it feels so damn good after all the studies and all these years that this drug is FINALLY in the hands of the FDA!

business-result

Its innovative platform technologies, promising clinical trial results, strong pipeline of product candidates, and partnerships with industry leaders all position the company for success.

NOVN will probably post an excellent 4th quarter from a financial standpoint along with good news on the drugs in development.

$NOVN fourth quarter will beat third easily. Catalyst.

At approval, which it will get approved based on the study results, this goes above $20 easily likely even with a raise in between above $10

I’m here for the ride.

Regardless, Novan has a drug that shows stellar safety profile and significant results.

As for getting approval on our first shot, the results did well.

$NOVN 

By the way, as if the outstanding results on sb206 weren’t enough, COVID is on the rise again and their Nitricil technology is also going to get traction with pending government grant in case you didn’t already know.

Happy as hell to be here 

*side note: $NOVN has a drug with absolutely massive Ph3 results that will be approved in 2023.

The first quarter of next year should continue this trend as this is where the biotech sector usually has its strongest market cycle of the year.

$NOVN 

Revenue up significantly compared to last year same Quarter.

KemPharm Inc

If the current staff is not able to get the job done, why are we still paying them?

but sho nuff in a mood about Corium not doing their job.

but still seeing plenty of reports of Azstarys availability issues at pharmacies (Coriums job).

KEEP YOUR FOCUS ON AZSTARYS AND DO YOUR DAMN JOB.

$KMPH Honest question, who keeps their high paying job and salary when you continually fail to deliver to share holders?

He’s done a bang-up job for them while shuttle cocking us!

$KMPH Richard Pascoe should be immediately fired from his phony do nothing job at Kempharm.

But yeah Corium and it&#39;s sales reps suck and are doing a bad job.

But I thought Travis was doing a good job?? !

hand

Warrants/Option have been handed out like candy on Halloween, decreasing shareholder value.

In mentioning the changes and additions, I noticed he didn&#39;t mention all these options/warrants they handed out reducing shareholder value.

We hand it over to Corium and they completely drop the ball and sales suck.

I went all in on kmph, and for the first time in a while, I don&#39;t feel great about the cards in my hand.

Create a new position or something to hand hold Perrys dumbass through this.

$KMPH Too bad Azstarys isn’t a schedule 19 drug, KemPharm could REALLY hand out their medications today 😁

$KMPH I think it’s hysterical that The Board stated that they bring quality &amp; experience meanwhile the truth shows another picture.

but too small (market cap &amp; volume wise) for me

Please send Travis &amp; Laduane to investor presentation school or get someone on the call who gets importance of presentation.

Travis sounded like he was underwater and hungover, LaDuane sounded sheepish, and the Q&amp;A was like a sprint.

So far board &amp; mgmt have proven weak.

$KMPH too many whiners &amp; bitches here

Maybe you should have put out a disclaimer that past  performance does not indicate future results?

The top line results were written in scientific gibberish.

If NDA submission was next quarter no one would be selling off before that catalyst. Disappointing.

$KMPH 
We need better results from Corium- NOW.

Two more quarters is a hard turkey to swallow when you’ve been waiting 14. #annualholidaymicklecuck

Unfortunately  the boost for KMPH is nullified by Travis&#39;  extension of 2 more quarters of dullness

This is a 2 quarter delay, that definitely sucks,

But  at this moment it is hard for me to accept the fact that we are delayed by 2 quarters.

product

Crappy calls are a by product of all this.

Told you this was dead money with that horrible management team and generic product.

Gotta make sure they not jacked up on their own product!

The Q3 Arimoclomol NDA is certainly another growth catalyst.

This system and the way it is set up will serendipitously help our pps greatly come Q3 when KemPharm re-submits Arimoclomol&#39;s NDA.

Now that we know Arimoclomol&#39;s NDA is postponed till Q3, I truly believe we have a sleeper here.

Another drug that is up for NDA in a few months and a SDX drug better than any stimulant ever created.

It seems like a safe spot for a portfolio manager to park some funds in anticipation of Q1 NDA excitement.

growth

Add in a little growth, and Zevra is in the black by Q4.

The manufacturing, marketing and distribution ARE in place and the script numbers ARE showing very solid growth.

$KMPH Quite impressive growth in scripts!

This is the script growth I&#39;ve been waiting for.

$KMPH This week we have MoM script growth, 24%, and YoY script growth, 748%. Nice!

New treatments and product launches: The development and launch of new and innovative treatments for ADHD, such as extended-release formulations and combination products, is also driving market growth.

No wonder we are seeing the exponential sales growth! !

news

The good news is that once our catalysts hit, this will all be water under the bridge ✌🏻

$KMPH https://twitter.com/zevratx/status/1629141771887300616?s=46&amp;t=mKynV6sCCjZ8XQfM2ymhxA

Great news!! !

Nevertheless good news, as it means the previous script number wasn&#39;t an outliner in the other direction either.

however like $KMPH all good news as a company with tons of potential.

And 4 year study is complete that&#39;s great news.

The market futures (so far) are looking positive on a Monday?

I am pleased with the SP! !🫡
(Especially on a Red Market day)

Good thing the market as a whole is thriving today, 🤣.

This will be a winner take all market and it feels good to have chosen the right horse.

but now we have new market conditions we can only dream about.

$kmph Jumped back i pre market for 1k starter 5.40&#39;s  scripts this week are a blowout!

$KMPH Well if the market is voting on hires Gallo is a 👍 😂

but I also believe the market is full of opportunities nowodays.

cash

$IIPR one day the dividend will be $12 per year per share with these massively solid cash flows and zero debt.

Pascoe could ride off into the sunset in a couple years with tons of cash and the pride of look what I built.

CEO says ”company is great, we have cash forever and we have many milestones coming up”.

You actually gain short term benefit from it sdue to cash coming in.

$KMPH watch $GANX $43 mil cap $30 mil plus in cash chart is breaking out! 👀

Way more upside here with just cash value then anywhere else in the market.

$KMPH Cash position is outstanding, helped by a very efficient burn rate, and pipeline is advancing with 2 drugs that will have significant events in Q3 2023, and sales royalties from Corium will start ramping up in Q1.

Great science, drug, tech., potential and ridiculous valuation in relation to cash &amp; assets.

We have a winner here and a long cash runway.

Galera Therapeutics Inc

Pairing the fact that I think the chart is bullish + u guys&#39; confidence that NDA will be approved, this cud be a mega play

Good time to jump in , acceptance of NDA could come at any time.

NDA expected by EOY, I m glad to be here.

I kid, happy we are finally warming up for the NDA.

volume

$GRTX The volume increased for four consecutive days, resulting in a record-breaking daily growth of 209% of the 65-Day Volume Moving Average.

$GRTX The volume increased for two consecutive days, resulting in a record-breaking daily growth of 247% of the 65-Day Volume Moving Average.

$GRTX ok the daily chart setup looks good to me and all it needs is some volume.

$GRTX The volume increased for a consecutive 5 days, with an average daily gain of 800%.

Seems like everyone is moving into $KAL, volume and momentum are increasing here!!

NOVN

Novan Inc

-30.70%

$1.71 - $1.19

Mar, 6, 2023

Jan, 23, 2023

KMPH

KemPharm Inc

-26.64%

$5.63 - $4.13

Jan, 7, 2023

Jan, 3, 2023

Divihomes is Now Live

GRTX

Galera Therapeutics Inc

-11.06%

$2.26 - $2.01

Jan, 28, 2023

Jan, 12, 2023

NOVN

Novan Inc

-30.70%

$1.71 - $1.19

Mar, 6, 2023

Jan, 23, 2023

Jan, 6, 2023

Jan, 6, 2023

Jan, 5, 2023

Dec, 23, 2022

Nov, 14, 2022

Nov, 14, 2022

Oct, 31, 2022

KMPH

KemPharm Inc

-26.64%

$5.63 - $4.13

Jan, 7, 2023

Jan, 3, 2023

Nov, 26, 2022

Oct, 25, 2022

Oct, 4, 2022

GRTX

Galera Therapeutics Inc

-11.06%

$2.26 - $2.01